DTDaniel Tobler

Daniel Tobler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Tobler has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cardiac magnetic resonance T1 mapping predicts outcome in patients with a systemic right ventricle: a sub-analysis of the SERVE study

    by Odile Burdet, Kerstin Wustmann, Barbara E U Burkhardt, Emanuela R Valsangiacomo Buechel, Jean-Paul Vallée, Judith Bouchardy, Matthias Greutmann, Markus Schwerzmann, Harald Gabriel, Dominik Stambach, et al.

    Aims: In patients with a systemic right ventricle (sRV), the sRV is faced with an increased afterload compared to a right ventricle in sub-pulmonary position, leading to the development of fibrosis followed by ventricular dysfunction. Cardiac magnetic resonance (CMR) T1 mapping (T1) and its derived parameter, such as the extracellular volume (ECV), allow quantification of interstitial fibrosis. The SERVE study, a multicentric, placebo-controlled trial evaluated the effect of tadalafil in sRV patients. The aim of this sub-analysis of the SERVE trial was to evaluate (i) the relationship between T1 mapping parameters and the clinical composite endpoint of hospitalization for heart failure, clinically relevant arrhythmias, and all-cause mortality and (ii) their evolution over time, their correlation with CMR functional parameters, and the impact of study treatment. Methods and results: Patients included in the SERVE trial underwent a 1.5T CMR at baseline and at 1- and 3-year follow-up. For each CMR exam, native and post-contrast T1, as well as ECV, were calculated. In addition, late gadolinium enhancement (LGE) imaging was performed. Cardiac magnetic resonance was available for 60 patients. Native sRV T1 and ECV above the 75th percentile, but not LGE, were associated with the clinical composite endpoint. There was no significant change and no influence of tadalafil treatment on sRV T1 and ECV. Conclusion: T1 mapping as a non-invasive biomarker of the degree of myocardial fibrosis predicts outcome in patients with sRV and should be incorporated in risk stratification in these patients. The phosphodiesterase-5 inhibitor tadalafil appears to have no impact on the development of interstitial or macroscopic fibrosis.

  • Open Access

    Long-Term Postoperative Outcomes of Sinus Venosus Defect

    by Mariama Touray, Magalie Ladouceur, Judith Bouchardy, Markus Schwerzmann, Matthias Greutmann, Daniel Tobler, Reto Engel, Harald Gabriel, Caroline Blanche, Etienne Pruvot, et al.

    Background/Objectives: Despite advances in transcatheter therapy, surgery remains the gold standard treatment for sinus venosus defect (SVD). However, data on long-term outcomes following surgical repair remain scarce. This multicenter study evaluates the long-term outcomes of surgically treated SVD patients with comparison to surgically and percutaneously treated secundum atrial septal defect (ASD). Methods: Clinical, surgical, imaging and invasive data were retrospectively reviewed from eight centers in Europe. Results: A total of 209 patients were included, of whom 80 were surgically treated SVD, 57 surgically treated secundum ASD and 72 percutaneously treated secundum ASD. Operation for SVD mainly occurred in adulthood, with a median age of 28.5 years (2–68 years). During follow-up, the observed reoperation rate was higher in the SVD cohort than ASD cohorts (p = 0.033), despite shorter follow-up period in the SVD cohort. Reoperations, in the SVD cohort, occurred at a median of 28 years (1–50 years) after index surgery. The need for pacemaker implantation was similar between groups (p = 0.301). The prevalence of late atrial fibrillation did not differ between groups (p = 0.588). Surgically treated SVD tended to have a higher prevalence of atrial flutter and atrial tachycardia, with a significantly higher rate of electrophysiological studies than percutaneously treated secundum ASD (p = 0.013), similar to surgically treated secundum ASD (p = 0.405). Conclusions: Long-term follow-up of surgically treated SVD is essential to monitor for reintervention and arrhythmic complications.

  • Developing new approaches to mental health care for individuals with congenital heart disease: a tri-national qualitative study exploring health professionals’ views and experiences

    by Julia Baenziger, Madeleine Pidcock, Emily Jones, Jennifer Reiter-Purtill, Daniel Tobler, Nadine A Kasparian

    Objective: Increasingly, hospitals are recognizing the need to address the high mental health care needs of individuals with chronic illness, including congenital heart disease (CHD). This qualitative study explored health professionals’ views on integrated mental health care in CHD. Methods: Individual, semi-structured interviews were conducted with health professionals from diverse disciplines at five CHD centers in the United States, Australia, and Switzerland. Each center had a distinct model of mental healthcare integration and a unique healthcare ecosystem. The Consolidated Framework for Implementation Research was used to guide study design and analysis. Verbatim transcriptions were analyzed thematically using MAX Qualitative Data Analysis (MAXQDA) software. Results: Health professionals representing medicine, psychology, nursing, social work, education, and healthcare administration participated (N = 46, 58% response rate, 72% women, M = 15.5 ± 8.0 years of professional experience, interview duration: M = 47.9 ± 18.8 min). Five key themes were identified: (1) high need and demand for mental health care among individuals with CHD and their families; (2) multiple, inter-related barriers to care, including stigma and socioeconomic factors; (3) barriers to mental healthcare integration for CHD centers, including understaffing, time and fiscal constraints, and lack of clear referral pathways; (4) strategies to promote integration, including interdisciplinary teamwork and regular communication with mental health professionals embedded in cardiac care; and (5) facilitators of access to care, including routine mental health screening, multiple entry points across the medical trajectory, a preventive focus, and skills-based staff training. Conclusions: Results highlight the need for innovative implementation strategies to accelerate access to integrated mental healthcare for individuals with CHD across the lifespan.

  • Open Access

    Feasibility and accuracy of wearable electrocardiogram monitoring in adult congenital heart disease

    by Florine Runge, Jonas Brügger, Francisco Javier Ruperti-Repilado, Behnam Subin, Fabian Jordan, Corinne Isenegger, Christian Sticherling, Michael Kühne, Felix Mahfoud, Daniel Tobler, et al.


  • Open Access

    The importance of regional centres in the management of adults with congenital heart disease in Switzerland: a retrospective, multicentric cohort study

    by Mariella Machaczek, Francisco Javier Ruperti-Repilado, Fabian Tran, Simon F. Stämpfli, Dominik Stambach, Matthias Greutmann, Markus Schwerzmann, Daniel Tobler

    OBJECTIVE: We aimed to assess the extent of cardiac-related hospitalisations among adult congenital heart disease (ACHD) patients followed at Swiss regional ACHD centres. BACKGROUND: In Switzerland, adult congenital heart disease patients are followed at specialised ACHD centres. According to the Swiss recommendations for standards of adult congenital heart disease care,ACHD centres are categorised as regional and supraregional centres. In contrast to regional centres, supraregional centres require staffing for congenital cardiac surgery and complex congenital cardiac interventions. METHODS: Adult congenital heart disease patients enrolled in the SACHER registry and followed at one of three regional ACHD centres (University Hospital Basel, St Gallen Cantonal Hospital, Lucerne Cantonal Hospital) from May 2014 to March 2022 were included. Data were abstracted by chart review and included demographics, clinical and surgical history, follow-up duration and cardiac-related hospitalisations during follow-up. RESULTS: In total, 1031 patients (accounting for 22% of patients from the entire SACHER cohort) were included (570 at University Hospital Basel, 231 at St Gallen Cantonal Hospital, 230 at Lucerne Cantonal Hospital). During a median (IQR) follow-up of 3 (1–5) years, there were 237 hospitalisations (100 [42%] emergencies) among 136 (13%) patients. The majority of admissions (157, 66%), occurred at the regional centre. Arrhythmias (49 of 64 admissions, 77%) and heart failure hospitalisations (26 of 34, 76%) were mainly managed locally. The main reasons for referral to supraregional ACHD centres were heart surgery (32/56, 57%) and complex structural percutaneous interventions (pulmonary valve replacement [3/3, 100%] and balloon dilation of aortic coarctation [7/7, 100%]). CONCLUSION: In Switzerland, regional ACHD centres provide an important contribution to the management of the growing cohort of adult congenital heart disease patients. Most hospitalisations were managed locally. This was particularly true for emergencies, arrhythmia and heart failure hospitalisations. The main reasons for referral to supraregional ACHD centres were complex percutaneous interventions.

  • Open Access

    Association of reduced peak left atrial strain with supraventricular arrhythmia in adults with congenital heart disease

    by Clément Nussbaumer, Markus Schwerzmann, Elena Elchinova, Eleni Goulouti, Daniel Tobler, Matthias Greutmann, Kerstin Wustmann, Andrea Papa, Fabienne Schwitz

    Atrial arrhythmias are an important cause of morbidity and mortality in adults with congenital heart disease (ACHD). In acquired heart disease, the left atrial (LA) strain has been shown to predict supraventricular tachyarrhythmias (SVT). This study aimed to investigate whether reduced LA strain is associated with SVT in ACHD patients. This retrospective, single-center cohort study collected baseline clinical and echocardiographic data of 206 ACHD patients (157 left heart defect, 49 right heart defect). Patients with sinus rhythm at baseline and a 5-year follow-up (median age 29, IQR 22–41 years) were included. Diagnosis of sustained SVT was determined from clinical reports during the follow-up period. New or recurrent sustained SVT occurred in 16 patients (7.8%, median follow-up of 6.2 years). Patients who developed SVT were older, more likely to have diastolic dysfunction, and had larger LA dimensions, left ventricular mass, and a lower peak LA longitudinal strain (PALS). Lower PALS was associated with higher risk of SVT in patients with left and right heart defects. Patients in the lowest quartile for PALS had a 15.9-fold higher hazard ratio of SVT (95% confidence interval, 4.5 to 56.0, p < 0.001) in comparison with the top three quartiles. PALS provides information about the occurrence of SVT in the ACHD population. Including measurement of LA strain in the follow-up of these patients may allow to better identify patients at risk of future atrial arrhythmias. Graphical abstract


  • Open Access

    NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification?

    by Fabian Tran, Francisco Javier Ruperti-Repilado, Philip Haaf, Pedro Lopez-Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Juerg Schwitter, et al.


  • Open Access

    Prognostic Value and Determinants of High‐Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial

    by Francisco Javier Ruperti‐Repilado, Fabian Tran, Philip Haaf, Pedro Lopez‐Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Tobias Rutz, et al.

    Background: The determinants and prognostic value of high‐sensitivity cardiac troponin T (hs‐cTnT) among patients with a systemic right ventricle are largely unknown. Methods and Results: Ninety‐eight patients from the randomized controlled SERVE (Effect of Phosphodiesterase‐5 Inhibition With Tadalafil on Systemic Right Ventricular Size and Function) trial were included. The correlation between baseline hs‐cTnT concentrations and biventricular volumes and function quantified by cardiac magnetic resonance or cardiac multirow detector computed tomography was assessed by adjusted linear regression models. The prognostic value of hs‐cTnT was assessed by adjusted Cox proportional hazards models, survival analysis, and concordance statistics. The primary outcome was time to the composite of clinically relevant arrhythmia, hospitalization for heart failure, or all‐cause death. Median age was 39 (interquartile range, 32–48) years, and 32% were women. Median hs‐cTnT concentration was 7 (interquartile range, 4–11) ng/L. Coefficients of determination for the relationship between hs‐cTnT concentrations and right ventricular end‐systolic volume index and right ventricular ejection fraction (RVEF) were +0.368 ( P =0.046) and −0.381 ( P =0.018), respectively. The sex‐ and age‐adjusted hazard ratio for the primary outcome of hs‐cTnT at 2 and 4 times the reference level (5 ng/L) were 2.89 (95% CI, 1.14–7.29) and 4.42 (95% CI, 1.21–16.15), respectively. The prognostic performance quantified by the concordance statistics for age‐ and sex‐adjusted models based on hs‐cTnT, right ventricular ejection fraction, and peak oxygen uptake predicted were comparable: 0.71% (95% CI, 0.61–0.82), 0.72% (95% CI, 0.59–0.84), and 0.71% (95% CI, 0.59–0.83), respectively. Conclusions: Hs‐cTnT concentration was significantly correlated with right ventricular ejection fraction and right ventricular end‐systolic volume index in patients with a systemic right ventricle. The prognostic accuracy of hs‐cTnT was comparable to that of right ventricular ejection fraction and peak oxygen uptake predicted. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03049540.


  • Open Access

    High Variability of Right Ventricular Volumes and Function in Adults with Severe Pulmonary Regurgitation Late After Tetralogy of Fallot Repair

    by Matthias Greutmann, Javier Ruperti, Fabienne Schwitz, Nora Haag, Bruno Santos Lopes, Lukas Meier, Daniela Babic, Emanuela Valsangiacomo Buechel, Christian Kellenberger, Francesca Bonassin, et al.